| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.3 |